Individuals with clinical obesity often exhibit elevated insulin and HOMA-IR indices, yet maintain fasting glucose within the normal range or even slightly below that of preclinical individuals, due to compensatory hyperinsulinemia. This evidence concerns the gene INS and obesity disorder.